Title 21 Job Opportunities
The 21st Century Cures Act was enacted on December 13, 2016 and Section 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products. The FY23 Food and Drug Omnibus Reform Act expanded this authority further amending Title 21 to include cross-cutting operational positions and individuals that support the development review and regulation of food and cosmetics in addition medical products. (codified into Title 21 of the United States Code (21 US Code 379d-3a).
The positions listed below are being filled under Title 21. The candidate selected for these positions will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here
Title 21 Open Vacancies
Deputy Division Director
Center for Biologics Evaluation and Research (CBER)
Closing date: May 30, 2024
Health Scientist (Quality System Regulatory Review)
Center for Biologics Evaluation and Research (CBER)
Closing date: May 29, 2024
Mathematical Statistican
Center for Biologics Evaluation and Research (CBER)
Closing date: May 29, 2024
Deputy Office Director
The Center for Drug Evaluation and Research (CDER)
Closing Date: June 13, 2024
Science Disclosure Analyst
Center for Biologics Evaluation and Research (CBER)
Closing date: May 29, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing Date: July 22, 2024
Lead Clinical Laboratory Scientist
Center for Biologics Evaluation and Research (CBER)
Closing date: May 22, 2024
Senior Regulatory Counsel
Center for Food Safety and Applied Nutrition (CFSAN)
Closing Date: May 21, 2024
Information Technologist (Enterprise Architect)
Center for Biologics Evaluation and Research (CBER)
Closing date: May 21, 2024
Lead Regulatory Counsel
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 17, 2024
Deputy Division Director
Center for Biologics Evaluation and Research (CBER)
Closing date: May 15, 2024
Branch Chief
Center for Biologics Evaluation and Research (CBER)
Closing date: May 15, 2024
Branch Chief
Center for Biologics Evaluation and Research (CBER)
Closing date: May 15, 2024
Biologist
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 17, 2024
Chief Scientist
Office of the Commissioner (OC)
Closing date: June 3, 2024
Regulatory Counsel
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 31, 2024
Deputy Division Director
Center for Biologics Evaluation and Research (CBER)
Closing date: May 22, 2024
Deputy Office Director, Office of Neurological and Physical Medicine Devices
Center for Devices and Radiological Health (CDRH)
Closing date: May 29, 2024
Physician (Surgical Oncologist)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 31, 2024
Social Science Analyst (Band A/B/C)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 31, 2024
Social Science Analyst (Band D)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 31, 2024
Chemist (Advanced Analyst)
Office of Regulatory Affairs (ORA)
Closing date: July 26, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Investigator II / Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 15, 2024
Deputy Office Director (Supervisory Consumer Safety Officer) (AD-0696)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 15, 2024
Deputy Office Director (Supervisory Regulatory Counsel) (AD-0301)
The Center for Drug Evaluation and Research (CDER)
Closing Date: May 15, 2024
Physician
Center for Biologics Evaluation and Research (CBER)
Closing date: Open continuously; applications will be reviewed periodically
Investigator II/Senior Investigator I
Office of Regulatory Affairs (ORA)
Closing date: July 22, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: July 10, 2024
Investigator II
Office of Regulatory Affairs (ORA)
Closing date: May 31, 2024
Physician, Office of Therapeutic Products (OTP)
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically
Physician
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically.